Has Craig Thompson received payments from drug or device companies?

Yes. Drug and device makers reported $1,563 in general payments to Craig Thompson across 117 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Craig Thompson did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Craig Thompson come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Craig Thompson

Internal Medicine · Marion, OHNPI 1215995758

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AstraZeneca at 24.5% of the total. Reporting peaked in 2019 at $893 and has fallen 77.9% since, to $197 in 2021.

$1,563in general payments, 2019–2025

Across 117 payments — averaging $13.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$382
Novo Nordisk$321
Pfizer$191
Lilly USA, LLC$136
Merck$97
Astellas Pharma US Inc$68
plus $367 from 11 others

$402,871in research payments, 2019–2025

Across 15 payments — averaging $26,858 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Amgen$395K
Kowa Research Institute, Inc.$8K

What the payments were for

Food & beverage$1,563100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	12	$382
Novo Nordisk	29	$321
Pfizer	27	$191
Lilly USA, LLC	10	$136
Merck	7	$97
Astellas Pharma US Inc	5	$68
Novartis	5	$65
Johnson & Johnson	4	$58
Amgen	4	$53
AbbVie	2	$34
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$27
Amarin Pharma, Inc.	2	$25
GSK	2	$24
Biohaven Pharmaceuticals, Inc.	2	$23
Teva Pharmaceuticals USA, Inc.	1	$23
Sanofi Pasteur Inc.	2	$22
Sanofi-aventis U.S. LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,563 in reported general payments places this provider in the 80th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio →

Other internal medicine in Marion

Arthur ArmstrongMarion$44K
Hassan MalikAkron$1.7M
Cyrus HarrisCleveland$726K
Nina DeepWesterville$614K
Necklall KhooblallAustintown$448K
Daniel WeissMentor$406K
Richard KimDayton$326K
Marina MagreyCleveland$312K
Lisa LarkinCincinnati$276K
Gregg FaimanMayfield Hts$274K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →